SAHAREK JOHN P. 4
4 · HARROW HEALTH, INC. · Filed Jul 20, 2023
Insider Transaction Report
Form 4
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Tax Payment
Common Stock
2023-07-18$18.23/sh−109,080$1,988,528→ 222,197 total - Exercise/Conversion
Common Stock
2023-07-18+277,200→ 331,277 total - Exercise/Conversion
Performance Stock Unit
2023-07-18−277,200→ 0 total→ Common Stock (277,200 underlying)
Footnotes (1)
- [F1]The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.